S100A9 Lysate
- Known as:
- S100A9 Lysate
- Catalog number:
- NBL1-15660
- Product Quantity:
- 0.1 mg
- Category:
- -
- Supplier:
- ACR
- Gene target:
- S100A9 Lysate
Related genes to: S100A9 Lysate
- Gene:
- S100A9 NIH gene
- Name:
- S100 calcium binding protein A9
- Previous symbol:
- CAGB, CFAG
- Synonyms:
- P14, MIF, NIF, LIAG, MRP14, MAC387, 60B8AG, CGLB
- Chromosome:
- 1q21.3
- Locus Type:
- gene with protein product
- Date approved:
- 1989-05-19
- Date modifiied:
- 2018-05-02
Related products to: S100A9 Lysate
Related articles to: S100A9 Lysate
- Cancer-associated cachexia (CAC) is a multifactorial wasting syndrome characterized by progressive loss of fat and lean mass, systemic inflammation, and poor therapeutic responsiveness. While brown adipose tissue (BAT) is traditionally considered a protective, energy-dissipating organ, its qualitative remodeling in CAC remains poorly characterized.Here, we demonstrate that CAC induces a senescent conversion of BAT, marked by thermogenic failure, fibrosis, inflammation, and acquisition of a senescence-associated secretory phenotype (SASP). Through integrative transcriptomic, proteomic, and secretomic analyses in a murine model of lung cancer-induced cachexia, we identify S100A9 as a key factor selectively upregulated and secreted by brown adipocytes. Functional assays reveal that the BAT secretome exerts deleterious paracrine effects on white adipocytes and skeletal myotubes, promoting lipolysis and atrophy, while also impairing brown adipocyte identity in an autocrine manner. Co-culture and gain-of-function experiments with S100A9 recapitulate these phenotypes in vitro in mouse and human brown adipocytes, whereas pharmacological blockade of S100A9 signaling partially restores thermogenic and metabolic features. Collectively, our findings reveal that BAT undergoes functional reprogramming into a senescent and secretory tissue in cancer cachexia, with adipocyte-derived S100A9 acting as a novel pro-cachectic mediator. This work redefines the role of BAT in CAC and identifies S100A9 as a potential therapeutic target within the adipose-muscle crosstalk. - Source: PubMed
Publication date: 2026/05/02
Di Biagio ClaudiaTortolici FlaviaGaudioso FrancescoNinni AndreaGiurdanella Annina FrancescaDe Ranieri ChiaraZaccaria FabioSciarretta FrancescaLuca VerteramoArciprete FrancescaCarotti SimoneAf de Vries AntoineKooijman SanderPacello FrancescaBattistoni AndreaLettieri-Barbato DanieleAquilano Katia - Autism spectrum disorder (ASD) is a complex neurodevelopmental condition often accompanied by gastrointestinal (GI) symptoms. Inflammatory proteins in stool have been proposed as potential biomarkers, but evidence remains inconsistent. We compared fecal levels of α1-antitrypsin (A1AT), immunoglobulin A (IgA), and calprotectin (Cal) in 57 children with ASD and 57 biological siblings without ASD. Sibling designs are now preferred to disentangle ASD-specific biology from shared environmental and microbiome factors. Participants were carefully screened to exclude recent antibiotic use, digestive problems, gastrointestinal infections, and abnormal dietary patterns, thereby controlling for major factors known to influence gut inflammatory markers. - Source: PubMed
Publication date: 2026/04/15
Osredkar JoškoFinderle PetraGodnov UrošJekovec-Vrhovšek MajaVidova VeronikaElliott James PriceFabjan TejaAvguštin GorazdOsredkar DamjanKumer Kristina - Psoriasis and metabolic dysfunction-associated fatty liver disease (MAFLD) share pathological features such as chronic inflammation, immune dysregulation, and metabolic disturbance. Increasing evidence suggests biological crosstalk between the two conditions, offering new insights into their shared mechanisms and comanagement. Early-stage MAFLD, characterized by hepatic steatosis without evident inflammation or fibrosis, provides a crucial window for intervention. This study aimed to identify early diagnostic biomarkers linking psoriasis and MAFLD. - Source: PubMed
Publication date: 2026/04/15
Wang ShanshanChen YanfangYang TingtingZhang DamingLiu YadiZhang ShenglanYang ZishanWei TuanjieQiu LizhenHuang FangXiao Zhiqiang - The cellular heterogeneity and molecular complexity of pulmonary arterial hypertension (PAH) have not been fully elucidated. - Source: PubMed
Publication date: 2026/04/15
Yang YuanqiLei YangWu BojiNing KeShen YangWang XuhongHe JingyuZhang JihangLiu ChuanQin Zhexue - To observe the therapeutic effect of Zaozhu Yinchen Decoction (ZZYC) on rats with non-alcoholic steatohepatitis (NASH) and explore its mechanism of action related to myeloid-derived suppressor cells (MDSCs). - Source: PubMed
Publication date: 2026/04/24
Zhang WenyangWang YujieLiu YaoyuZheng XiaotingWang TianxiangKwan XinyiLiu RuobingLiu QiZhuang HongliLiang HuiqingChen Shaodong